성장호르몬 분비의 신경내분비적 조절기전
Neuroendocrine Regulation of Growth Hormone Secretion
2
조회
0
다운로드
1
인용
0
참고문헌
키워드
초록
The regulation of growth hormone (GH) secretion is, to a larger extent, controlled by three hypothalamic hormones: GH-releasing hormone (GHRH), somatostatin, and ghrelin. Each binds to G protein-linked membrane receptors through which signaling occurs. We used a series of genetic and transgenic animal models with perturbations of individual compounds of the GH regulatory system to study somatotrope signaling. Impaired GH signaling is present in the lit mouse, which has a GHRH receptor (GHRH-R) mutation, and the dw rat, which has a post-receptor signaling defect. Both models also have impaired response to GH secretagogues (GHS), implying an interaction between the two signaling systems. The spontaneous dwarf rat (SDR), in which a mutation of the GH gene results in total absence of the hormone, shows characteristic changes in the hypothalamic regulatory hormones due to an absence of GH feedback and alterations in the expression of each of their pituitary receptors. Treatment of SDRs with GHRH and a GHS has allowed demonstration of a stimulatory effect GHRH on GHRH-R and GHS-R, and somatostatin receptor type 2 (sst2) expression and an inhibitory effect on sst5 expression. GH also modifies the expression of these receptors, though its effects are seen at later time periods and appear to be indirect. In the absence of GH negative feedback, both hypothalamic and pituitary expression is altered to favor stimulation of GH synthesis and release. However, in the presence of GH negative feedback, both hypothalamic and pituitary expression is altered to favor suppression of GH synthesis and release. Loss of liver insulin-like growth factor I (IGF-I) feedback on the hypothalamic-pituitary system increases GH secretion, which, in turn, stimulates liver growth. Depletion of liver-derived IGF-I increases the expression and sensitivity of pituitary GHRH-R and GHS-R. The major site of action of liver-derived IGF-I in the regulation of GH secretion is at the pituitary level. Neuropeptide Y (NPY) is not required for basal regulation of the GH axis. NPY is required for fasting-induced suppression of GHRH and SRIH expression. NPY is also required for fasting-induced augmentation of pituitary GHS-R mRNA. Overall, the results indicate a complex regulation of GH secretion in which somatotrope receptor, as well as ligand expression, exerts an important physiological role.
Abstract
The regulation of growth hormone (GH) secretion is, to a larger extent, controlled by three hypothalamic hormones: GH-releasing hormone (GHRH), somatostatin, and ghrelin. Each binds to G protein-linked membrane receptors through which signaling occurs. We used a series of genetic and transgenic animal models with perturbations of individual compounds of the GH regulatory system to study somatotrope signaling. Impaired GH signaling is present in the lit mouse, which has a GHRH receptor (GHRH-R) mutation, and the dw rat, which has a post-receptor signaling defect. Both models also have impaired response to GH secretagogues (GHS), implying an interaction between the two signaling systems. The spontaneous dwarf rat (SDR), in which a mutation of the GH gene results in total absence of the hormone, shows characteristic changes in the hypothalamic regulatory hormones due to an absence of GH feedback and alterations in the expression of each of their pituitary receptors. Treatment of SDRs with GHRH and a GHS has allowed demonstration of a stimulatory effect GHRH on GHRH-R and GHS-R, and somatostatin receptor type 2 (sst2) expression and an inhibitory effect on sst5 expression. GH also modifies the expression of these receptors, though its effects are seen at later time periods and appear to be indirect. In the absence of GH negative feedback, both hypothalamic and pituitary expression is altered to favor stimulation of GH synthesis and release. However, in the presence of GH negative feedback, both hypothalamic and pituitary expression is altered to favor suppression of GH synthesis and release. Loss of liver insulin-like growth factor I (IGF-I) feedback on the hypothalamic-pituitary system increases GH secretion, which, in turn, stimulates liver growth. Depletion of liver-derived IGF-I increases the expression and sensitivity of pituitary GHRH-R and GHS-R. The major site of action of liver-derived IGF-I in the regulation of GH secretion is at the pituitary level. Neuropeptide Y (NPY) is not required for basal regulation of the GH axis. NPY is required for fasting-induced suppression of GHRH and SRIH expression. NPY is also required for fasting-induced augmentation of pituitary GHS-R mRNA. Overall, the results indicate a complex regulation of GH secretion in which somatotrope receptor, as well as ligand expression, exerts an important physiological role.
참고문헌 (25)
- Frohman LA, "Secretagogues and the somatotrope: signaling and proliferation", Recent Prog Horm Res, 55, pp.269~291 (2000)
- Frohman LA, "Growth hormone-releasing hormone: discovery, regulation, and actions. In: Handbook of Physiology: Hormonal Control of Growth.", pp.189~221 (1999), Oxford University Press
- Kojima M, "Ghrelin: discovery of the natural endogenous ligand for the growth hormone secretagogue receptor", Trends Endocrinol Metab, 12, pp.118~122 (2001)
- Kojima M, "Ghrelin: structure and function", Physiol Rev, 85, pp.495~522 (2005)
- Kojima M, "Structure and function of ghrelin", Results Probl Cell Differ, 46, pp.89~115 (2008)
- Tannenbaum GS, "Somatostatin. In:The Endocrine System: Hormonal Control of Growth", pp.221~265 (1999), Oxford University Press
- Kumar U, "Expression of the five somatostatin receptor (SSTR1-5) subtypes in rat pituitary somatotropes: quantitative analysis by double- layer immunoflourescence confocal microscopy", Endocrinology, 138, pp.4473~4476 (1997)
- Mezey E, "Cell specific expression of the sst2A and sst5 somatostatin receptors in the rat anterior pituitary", Endocrinology, 139, pp.414~419 (1998)
- Rohrer SP, "Rapid identification of subtype-selective agonists of the somatostatin receptor through combinatorial chemistry", Science, 282, pp.737~740 (1998)
- Gahete MD, "Understanding the multifactorial control of growth hormone release by somatotropes: lessons from comparative endocrinology", Ann N Y Acad Sci, 1163, pp.137~153 (2009)
- Burton KA, "Identification of target cells for growth hormone's action in the arcuate nucleus", Am J Physiol, 269, pp.E716~722 (1995)
- Chan YY, "Regulation of hypothalamic neuropeptide-Y neurons by growth hormone in the rat", Endocrinology, 137, pp.1319~1325 (1996)
- Kamegai J, "Growth hormone receptor gene is expressed in neuropeptide Y neurons in hypothalamic arcuate nucleus of rats", Endocrinology, 137, pp.2109~2112 (1996)
- Kamegai J, "Growth hormone induces expression of c-fos gene on hypothalamic neuropeptide-Y and somatostatin neurons in hypophysectomized rats", Endocrinology, 135, pp.2765~2771 (1994)
- Minami S, "Systemic administration of recombinant human growth hormone induces expression of the c-fos gene in the hypothalamic arcuate and periventricular nuclei in hypophysectomized rats", Endocrinology, 131, pp.247~253 (1992)
- Luque RM, "Effects of leptin replacement on hypothalamic-pituitary growth hormone axis function and circulating ghrelin levels in ob", ob mice, 2007, pp.292, E891~899
- Charlton HM, "Growth hormone-deficient dwarfism in the rat: a new mutation", J Endocrinol, 119, pp.51~58 (1988)
- Takeuchi T, "Molecular mechanism of growth hormone (GH) deficiency in the spontaneous dwarf rat: detection of abnormal splicing of GH messenger ribonucleic acid by the polymerase chain reaction", Endocrinology, 126, pp.31~38 (1990)
- Kamegai J, "Hypothalamic", pituitary-axis of the spontaneous dwarf rat: autofeedback regulation of growth hormone (GH) includes suppression of GH releasing-hormone receptor messenger ribonucleic acid, 1998, pp.139, 3554~3560
- Peng XD, "The growth hormone (GH)-axis of GH receptor", binding protein gene-disrupted and metallothionein- human GH-releasing hormone transgenic mice: hypothalamic neuropeptide and pituitary receptor expression in the absence and presence of GH feedback, 2001, pp.142, 1117~1123
- Wallenius K, "Liver-derived IGF-I regulates growth hormone (GH) secretion at the pituitary level in mice", Endocrinology, 142, pp.4762~4770 (2001)
- Erickson JC, "Sensitivity to leptin and susceptibility to seizures of mice lacking neuropeptide Y", Nature, 381, pp.415~421 (1996)
- Sainsbury A, "Inhibitory effects of central neuropeptide Y on the somatotropic and gonadotropic axes in male rats are independent of adrenal hormones", Peptides, 22, pp.467~471 (2001)
- Suzuki N, "Inhibitory effect of neuropeptide Y on growth hormone secretion in rats is mediated by both Y1- and Y2-receptor subtypes and abolished after anterolateral deafferentation of the medial basal hypothalamus", Regul Pept, 65, pp.145~151 (1996)
- Park S, "Expression analysis of hypothalamic and pituitary components of the growth hormone-axis in fasted and streptozotocin-treated NPY intact(NPY+", +) and NPY knockout(NPY-, Neuroendocrinology, pp.2005, 81[DOI]